The goal of Broadpoint Capital's research team is to deliver value-added investment ideas that enhance the investment returns of our institutional clients. Through our senior equity analysts, Broadpoint focuses their research efforts on small to mid-capitalization stocks in emerging growth industries within the Energy, Healthcare and Technology sectors. Our analysts typically have extensive practical experience in their industry sectors, and each is established as a thought leader in his or her field.

Delivering successful investment ideas to our clients is achieved through a research methodology that integrates in-depth quantitative and qualitative research, intensive primary research analysis, and field work which accesses the knowledge and opinions of industry experts, suppliers and end-users. The result is our analysts' ability to distill their findings down to a value-added, and when appropriate, non-consensus investment conclusion.



Industry Focus

  • Energy - CleanTech and Exploration & Production
  • Healthcare - Biotechnology, Global Specialty Pharmaceuticals, and Healthcare Services
  • Technology - Advanced Materials, Enterprise Application Software, Semiconductors/Semiconductor Capital Equipment

Research Coverage Universe
View the latest pricing chart provided by BlueMatrix.
Learn More

Transparency of Analysts' Performance
Broadpoint's rating system.
Learn More

Christina Rizopoulos Valauri
Director of Equity Research

Thomas Covington
Managing Director

Gavin Duffy
Principal

Glenn Garmont
Principal

Avinash Kant, Ph.D.
Principal

David Lickrish, CFA
Principal

Ronald A. Oster
Principal

Colin W. Rusch
Vice President

Simos Simeonidis, Ph.D.
Vice President

David Webber
Managing Director

Bradley Whitt
Managing Director

© 2007 Broadpoint
Home  |  Contact Us  |  Disclosures  |  Privacy Policy  |  Careers